Olopatadine Hydrochloride Ophthalmic Solution Study in Chinese Subjects

NCT02322216 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

383

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Conjunctivitis

Interventions

DRUG: Olopatadine Hydrochloride Ophthalmic Solution 0.2%
DRUG: Olopatadine Hydrochloride Ophthalmic Solution 0.1%
DRUG: Olopatadine 0.2% Vehicle

Sponsor

Alcon Research